210 related articles for article (PubMed ID: 15081192)
1. Pharmaceuticals in Australia: developments in regulation and governance.
Lofgren H; Boer Rd
Soc Sci Med; 2004 Jun; 58(12):2397-407. PubMed ID: 15081192
[TBL] [Abstract][Full Text] [Related]
2. A perspective on Australia's National Medicines Policy.
Tett SE
Can J Clin Pharmacol; 2004; 11(1):e28-38. PubMed ID: 15226524
[TBL] [Abstract][Full Text] [Related]
3. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
Doran E; Alexander Henry D
J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
[TBL] [Abstract][Full Text] [Related]
4. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
Morgan S; McMahon M; Greyson D
Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Australia's National Medicines Policy using geographical mapping.
Roughead EE; Monteith GR; Harvey KJ; Tett SE
Intern Med J; 2002 Mar; 32(3):66-71. PubMed ID: 11885845
[TBL] [Abstract][Full Text] [Related]
6. Future European health care: cost containment, health care reform and scientific progress in drug research.
Emilien G
Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
Lopert R
Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
[TBL] [Abstract][Full Text] [Related]
8. An analysis of China's national essential medicines policy.
Guan X; Liang H; Xue Y; Shi L
J Public Health Policy; 2011 Aug; 32(3):305-19. PubMed ID: 21614030
[TBL] [Abstract][Full Text] [Related]
9. Prescription drug benefits for seniors and public/private collaboration.
Brekke M
Beginnings; 2002; 22(3):11. PubMed ID: 12046112
[No Abstract] [Full Text] [Related]
10. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
Lipworth W; Doran E; Kerridge I; Day R
Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
[TBL] [Abstract][Full Text] [Related]
11. Toward a national health risk management approach in Australia.
O'Donnell C
J Allied Health; 2002; 31(1):10-4. PubMed ID: 11905388
[TBL] [Abstract][Full Text] [Related]
12. PBS medications--improving access for Aboriginal and Torres Strait Islander peoples.
Couzos S
Aust Fam Physician; 2005 Oct; 34(10):841-4. PubMed ID: 16217569
[TBL] [Abstract][Full Text] [Related]
13. Public preferences and organized interests in health policy: state pharmacy assistance programs as innovations.
Gray V; Lowery D; Godwin EK
J Health Polit Policy Law; 2007 Feb; 32(1):89-129. PubMed ID: 17312326
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity.
Compagni A; Cavalli L; Jommi C
Health Policy; 2008 Sep; 87(3):333-41. PubMed ID: 18384907
[TBL] [Abstract][Full Text] [Related]
15. Developing an equivalent to the National Medicines Policy for medical devices.
Smith MW; Faunce TA
J Law Med; 2009 Dec; 17(3):412-25. PubMed ID: 20169801
[TBL] [Abstract][Full Text] [Related]
16. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
[TBL] [Abstract][Full Text] [Related]
17. A pharmaceutical perspective of Australia's Health Benefits Program.
Elzarian EJ
J Am Pharm Assoc; 1975 Dec; 15(12):695-8, 708. PubMed ID: 1206197
[No Abstract] [Full Text] [Related]
18. Pharmaceutical policy in China.
Sun Q; Santoro MA; Meng Q; Liu C; Eggleston K
Health Aff (Millwood); 2008; 27(4):1042-50. PubMed ID: 18607039
[TBL] [Abstract][Full Text] [Related]
19. [Pharmaceuticals: a strategic national industry].
Hollender L
Bull Acad Natl Med; 2004; 188(4):701-13. PubMed ID: 15587688
[TBL] [Abstract][Full Text] [Related]
20. Australia's pharmaceutical benefits system: flawed but improving, and better than anywhere else.
Dalton A
Aust Health Rev; 2001; 24(2):7-14. PubMed ID: 11496474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
